Cargando…
Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470380/ https://www.ncbi.nlm.nih.gov/pubmed/36110896 http://dx.doi.org/10.2147/PHMT.S334744 |
_version_ | 1784788829561946112 |
---|---|
author | Gibler, Robert C Knestrick, Kaelynn E Reidy, Brooke L Lax, Daniel N Powers, Scott W |
author_facet | Gibler, Robert C Knestrick, Kaelynn E Reidy, Brooke L Lax, Daniel N Powers, Scott W |
author_sort | Gibler, Robert C |
collection | PubMed |
description | Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of these headaches. The burden and impact of chronic migraine in the daily lives of children and adolescents is substantial, requiring a holistic, multidisciplinary, and biopsychosocial approach to conceptualization and treatment. The purpose of this review is to provide a comprehensive “2022” overview of acute and preventive treatments for the management of chronic migraine in youth. We first describe diagnostic criteria for chronic migraine and highlight the state of evidence for acute and preventive treatment in children and adolescents. We then discuss emerging treatments currently receiving rigorous clinical research effort, special considerations for the treatment of chronic migraine in children and adolescents, and avenues for improving existing treatments and expanding access to evidence-based care. |
format | Online Article Text |
id | pubmed-9470380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-94703802022-09-14 Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? Gibler, Robert C Knestrick, Kaelynn E Reidy, Brooke L Lax, Daniel N Powers, Scott W Pediatric Health Med Ther Review Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of these headaches. The burden and impact of chronic migraine in the daily lives of children and adolescents is substantial, requiring a holistic, multidisciplinary, and biopsychosocial approach to conceptualization and treatment. The purpose of this review is to provide a comprehensive “2022” overview of acute and preventive treatments for the management of chronic migraine in youth. We first describe diagnostic criteria for chronic migraine and highlight the state of evidence for acute and preventive treatment in children and adolescents. We then discuss emerging treatments currently receiving rigorous clinical research effort, special considerations for the treatment of chronic migraine in children and adolescents, and avenues for improving existing treatments and expanding access to evidence-based care. Dove 2022-09-09 /pmc/articles/PMC9470380/ /pubmed/36110896 http://dx.doi.org/10.2147/PHMT.S334744 Text en © 2022 Gibler et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Gibler, Robert C Knestrick, Kaelynn E Reidy, Brooke L Lax, Daniel N Powers, Scott W Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? |
title | Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? |
title_full | Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? |
title_fullStr | Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? |
title_full_unstemmed | Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? |
title_short | Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? |
title_sort | management of chronic migraine in children and adolescents: where are we in 2022? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470380/ https://www.ncbi.nlm.nih.gov/pubmed/36110896 http://dx.doi.org/10.2147/PHMT.S334744 |
work_keys_str_mv | AT giblerrobertc managementofchronicmigraineinchildrenandadolescentswherearewein2022 AT knestrickkaelynne managementofchronicmigraineinchildrenandadolescentswherearewein2022 AT reidybrookel managementofchronicmigraineinchildrenandadolescentswherearewein2022 AT laxdanieln managementofchronicmigraineinchildrenandadolescentswherearewein2022 AT powersscottw managementofchronicmigraineinchildrenandadolescentswherearewein2022 |